Collecting past footprint towa

Professor Shi yuankai Tribune: can you talk about this year's keynote report set to be an international forum designed it?stone Professor: Medical Oncology today, only half a century of history. After entering the 21st century, medical oncology treatment from conventional cytotoxic drugs as the principal of the treatment, into cytotoxic drugs as the basis, targeting drug growing more and more important position, we enter the patients genetic background and molecular expression products, to &ldquo it; the difference ” treatment times. In this context, medical oncology physicians how to grasp and meet the development trend of the times? Chinese doctors are concerned, because of differences in race and genetic background, we have created more and more to explore this opportunity of national characteristics and modes of therapy in patients with cancer, how are we going to play their role?in view of this, this year's annual meeting in “ past, present and future of medical oncology ” as the theme, has set up a special forum, this is the only theme of a conference report, in my opinion, this concert for all medical oncology doctor, even medical workers is of great significance in the field.at the same time, this year is the Conference of medical oncology (CSMO) 5th year, is also in honour of the past 5 years, we had such a forum, invited from the United States, Europe and Japan's top experts, and our adhering and Guan Zhong-Zhen: Professor, academician, speaking for different themes, looking back and looking forward to the future. It turns out that we have also listened to a really good and successful academic reports.Tribune: in processes of individual treatment of cancer, cancer doctors in China face what challenges?Shi yuankai Professor: I think that is mainly in the areas of clinical research and study on transformation of. Only to raise the level of clinical research, strengthened, deeper into the transformational research done will it be possible to get more experience, get more data for our own patients, more outcomes for our patients to share.at present, the main research results have come from Europe, the United States and Japan. Over the years, Chinese scholars ' research began in an important international meeting, but I think the number is too small. Now,   national on this aspects given has great concern, in “863” plans, and “ Eleven-Five ” and “ Twelve-Five ” major new drug creation, and major technology special, related project in the,   inputs has quite more of funding,   encourages China Medical territories of people with lofty ideals were to established a full of including clinical Qian research and clinical research zainei of new drug research and development system. This will enhance the research ability,   speed up research and raise the level of study. This is one aspect of Chinese doctors should be able to do.on the other hand is how to regulate the treatment of behaviour? Individualized treatment is not under treatment, should individual treatment based on strict clinical treatment. First principles, then to talk about the individual, both. In my opinion, these two aspects is that we should continue to strengthen, this calls for our entire industry practitioners constantly improve their knowledge, improve their knowledge structure, track the latest development of international, doing so can keep pace with the times, always stand in the forefront of the times. The main purpose of this is our CSMO —— Exchange results, solidifying consensus, update knowledge.Tribune: compared with previous years, the current session of the General Assembly what are the characteristics?Professor Shi yuankai: through the past 4 years of development, China Medical Oncology fellow us such a meeting has been widely recognized as one of the medical oncology in China scholars Exchange platform, it not only looks forward to the field of Chinese medical oncology fellow, also becomes committed to transforming research, basic research and drug develo

Cluster strategy to improve pr

Peking Union Medical College Hospital intensive care (ICU), a "cluster" therapeutic strategies, so that the hospital mortality of severe infection in immunosuppressive population from 78.6% per cent. &Nbsp; the so-called "cluster" policy refers to, is effective in reducing severe infection in immunosuppressive population death rate of a variety of treatment measures for induction, selection, based on treatment demand developed a detailed flowchart in chronological order, each step in the process of strict time limits, so that every patient can require time to be the most effective treatment. &Nbsp; in the treatment of severe infection in immunosuppressed populations, "cluster" implementation of the strategy include the correct decision, support, treatment and health care combined with three important content. ICU physician first need of patient history, early treatment, clinical manifestation, caters, image data, organ function, such as rapid assessment, make a preliminary judgment quickly. If you suspect that the patients are infections you will need to leave a culture samples in 1 hour and the rational use of antibiotics; if patients complicated by organ dysfunction, physicians complete shock and resuscitation in 6 hours is required, within 24 hours of taking a series of organ protection and support measures to win precious time for onset of antibiotics. Physician combination biomarkers in 24-48 hours, microbiology or invasive examination results, further titration antibiotics so that patients most appropriate treatment within shortest time on. &Nbsp; can say "cluster" policy listed at each point in time the established objectives and specific programmes to ensure its implementation. Programme implementation is required for each step in the best health care cooperation. Since 2006, the ICU application "cluster" strategic guide to the treatment of such patients (a total of 103 cases), so that the mortality from 78.6% per cent of the population, achieved encouraging results.   

Slow myopia of combination

&Nbsp, community questions and answers, a general practitioner asked: myopia is a common childhood eye disease, a variety of reasons, more and more children and young people now wear glasses as early, is there any way to slow the pace of development of myopia?　　Experts pointed out that the adoption of the following four methods may be able to control myopia progression in children. Participate in small ball games for children and young people can often play badminton or table tennis, play in the process of eyes follow the ball to come and go quickly. As the ball when high speed flying, ciliary muscle contraction and Suspensory ligament relaxation, rely on their own flexibility curvature of lens larger, diopter increase, to see where the ball direction when you go back to the ball far, exactly the opposite, ciliary muscle relaxation, Suspensory ligament strain, the lens becomes flat, to ensure that saw the ball in the distance.　　In successive hit back in the ball, key part of the eyeball in the children and young people exercise to curb development of amblyopia and myopia, even for turb eye (ocular), there is a secondary effect. Adjunctive therapy of traditional Chinese medicine now, many hospital ear holographic pure natural therapy, is based on the traditional theory of Meridian theory of traditional Chinese medicine and acupuncture as a treatment.　　Organ and corresponds to the connection between Auricular points Meridian, ear acupoint therapy is through the corresponding to the relevant organs of vision acuity of Auricular acupoint pressing to stimulate, through channel conduction regulating Zang-Fu viscera balance, improving blood circulation and nutrient supply, recovery self-regulating function of the eye, in order to effectively improve eyesight.　　At the same time, ear acupoint therapy is a pure natural method, is user-friendly, children and young people only care one or two times a week, then spend 20 minutes a day on its own pressing ear point to achieve a certain effect. RGP RGP also known as rigid gas permeable contact lenses. It uses special made from hard materials of high-oxygen, not direct contact with the corneal epithelium, but every tear layer for oxygen exchange, have good wettability and stain resistance. Wear RGP is closest to normal eyes can make children and youth with Visual effects.　　Simultaneously because lens quality is hard, blink time may have some compression effect on corneal, the corneal flattening, thereby reducing corneal diopter and corneal astigmatism and total diopter control eye development. OK OK microscopy (Orthokeratology) is a high-oxygen-permeable rigid corneal reshaping lenses only while sleeping in front of the cornea. It mirrors the Central arc of smaller than the cornea and lens peripheral cornea in the arc of fixed and increasing pressure on Central corneal, and gradually make corneal curvature, axial shortening.　　Due to the night lens has changed the shape of the cornea, myopia in children and adolescents receive a certain amount of control, if long-term use can play a preventive and curative effects of myopia.　　RGP and indications of OK lens has its strict, must be obtained vocational qualifications by medical institutions and instructions of doctors wearing, and young people also need to carry out the relevant checks and end before the wearing by a physician to determine whether together with. (&Nbsp of Jiangsu provincial people's Hospital Ophthalmology; Xie Zhan)  

Small artery prognosis and tre

Time: October 30, 16:10-16:30 location: Hall 5 small structural changes can be seen as resistance hypertension and ischemic heart disease, heart failure, ischemic attack and a critical link between renal failure. Generally agreed that resistance vessel structural abnormalities are common changes associated with chronic hypertension. Vessel wall thickness increases, together with smaller lumen may play an important role in the increased vascular resistance may also be increased hemodynamic load an adaptive response. Experimental study showed that small artery structural changes are normal thickness in hypertensive remodeling or reconstruction of hypertrophic (narrow the lumen same number around rearrange or smooth muscle cell hypertrophy of vascular wall material or proliferation) consequences. Vascular membrane and increase in the ratio of the lumen is of primary and secondary hypertension risk population in strong predictors of cardiovascular events. Recently, the subcutaneous prognostic significance of small resistance artery structural changes have been extended to any low to essential hypertension and cardiovascular risk of major cardiovascular events (myocardial infarction, stroke and sudden death). Research shows that after diludin calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in long-term effective treatment, small resistance vessel structure is likely to return fully to normal.　However, reverse vascular prognostic effect of structural changes is still not clear, there is need for trauma small prospective study, to clarify its role as antihypertensive treatment evaluate alternative end of May.   

Apasl 2009 will be held in Hon

18th Asia-Pacific Institute of liver (APASL) annual meeting to be held in Hong Kong in February 2009 to 13.　　Liao Jiajie, the President of the General Assembly by the Hong Kong University Professor, Hong Kong, China, this is the second time APASL annual meeting, also the first time by the Chinese experts to serve as President of the General Assembly.　　Of this annual meeting of the APASL theme "discussion on many aspects of clinical Hepatology (Multi-disciplinary Approach to Clinical Hepatology)", will be divided into several academic topics involving medicine, Hepatobiliary surgery and liver cancer, liver disease, liver transplantation, invited scholars to give lectures exchanges around the world. Please pay attention to meeting the official website at http://www.apasl2009hongkong.org.   

Antiviral treatment analysis

Antiviral therapy is chronic hepatitis b (CHB) key treatment strategy. Near 10  year long-acting interferons, lamivudine, adefovir dipivoxil, entecavir, for the beef and other drug research and development, provides new tools for hepatitis b treatment, use of antiviral drugs has been shown to reduce the incidence of cirrhosis, liver cancer. However these treatments is not completely clear the HBV,  HBV  cannot be solved; problems of persistent infections.　　　Authors according to their own clinical experience, analysis of current antiviral therapy for chronic hepatitis b status and difficult problems.　　　Status for patients with newly diagnosed hepatitis-b, optional treatment has two main programmes. Is interferon treatment, treatment is limited, its long-term clinical benefits have been verified, but there are still more drug side effects, problems of HBeAg serological conversion rate is not high. Second, nucleoside (acid) analogues, most patients are able to obtain good virological response, but need long-term medication, HBeAg serological conversion rate is not high, may lead to rebound after the withdrawal.　　　Now believe, serological conversion does not occur in patients with HBeAg-positive and HBeAg-negative hepatitis b patients need long-term use of nucleoside (acid) analogues, long-term medication can lead to resistance occurrence probability increases, brings new difficulties to clinical treatment.　　　Difficult mass antiviral drug for hepatitis b patients in recent 10 years, in addition to the emphasis on optimization of initial treatment in patients with treatment, the following situations will increasingly become the clinical treatment of difficulty. First, a large number of patients with refractory patients with hepatitis b will gradually become the main crowd   such as initial treatment for poor, stop the illness after repeated re-treatment of refractory chronic hepatitis b is the hard part.　　　After the initial treatment of patients with HBeAg-positive serological conversion HBeAg is available not only to the 30%; sequential monotherapy treatment led to multiple drug-resistant; treatment in patients with HBeAg-negative uncertainty, disease-prone rebounded after the withdrawal.　　　Secondly, the compensation period and antiviral treatment in patients with decompensated cirrhosis   mostly in patients with chronic hepatitis b transmission in China, the course of persisting with varying degrees of hepatic cirrhosis, seriously affecting the quality of life and become my liver, slow rush of severe hepatitis and liver failure, liver disease-related death of important reasons.　　　Finally, occult antiviral treatment for chronic hepatitis b   according to the report of investigation on HBsAg-negative people in different regions of China show that these populations HBV DNA positive rates as high as 5%. Studies have shown that clinically, obscure and unknown causes of cirrhosis, liver cancer hepatic dysfunction, of latent chronic hepatitis b, 30%, 20%. Probability of occult hepatitis b slow progress to cirrhosis over 50%, and associated with liver cancer. Thus reflects the occult slow hepatitis b clinical importance.   

Mitochondrial point mutations

Zhejiang University and Chinese Academy of engineering Academician Wang Shiwen Guan Minxin Professor leading the research team, in the study of the pathogenesis of hereditary hypertension, through to 1 typical matrilineal hereditary hypertensive pedigrees tracing study found that mitochondria 4,263 mutation causes high blood pressure.　　Research papers published online April 1, 2011 in the cycle (Circ Res) magazine. Since 2006, team for essential hypertensive pedigrees with maternally inherited features, for epidemiological, clinical medical and molecular genetic and cell biology aspects of in-depth study. In 2007, the research group discovered the 1 Han Chinese family with a typical maternally inherited characteristics. The family comes from hongtong County in Shanxi province. The researchers found that the pedigree with matrilineal mitochondrial 4,263 mutation carried by members. The family of 15 of the 27 members of the matrilineal relatives who suffers from high blood pressure, prevalence as high as 55.6%, is much higher than non-matriarchal members, showing genetic early onset phenomenon.　　This the group with United States Cincinnati and Austria Vienna Medical University collaboration in research found 4,263 mitochondrial point mutations, leading to mitochondrial dysfunction, thereby causing blood pressure. The researchers pointed out that, in patients with hypertension, about 8 million patients with high blood pressure or part under the influence of variation in mitochondria. The study, diagnosis and control on hypertension early stage genes, particularly targeting target treatment will have a profound impact, and for the study of hereditary hypertension has opened up new areas.    

Mitochondrial mutation caused

Incidence of hypertension in China more than 160 million people. PLA Wang Shiwen with Zhejiang University, academician Guan Minxin Professor leading the research team, has made new progress in the study on the pathogenesis of hereditary hypertension. Their Shanxi Hongdong County inherited hypertensive pedigrees tracing study found that 4,263 mitochondrial point mutations cause hereditary causes of hypertension is. The study, results published online April 1 in the cycling.hypertension affected by a number of complex common effects of environmental factors and genetic factors, genetic factors account for 30% per cent. In some patients with maternally inherited characteristics of typical and maternally inherited mitochondrial genetic material is unique to genetic patterns. At present, the international genetic study on the relationship between hypertension and mitochondrial small.beginning in 2006, Wang Shiwen and the research team led by Guan Minxin on pedigree with maternally inherited characteristics of primary Hypertension epidemiology, clinical medicine, molecular genetics and cell biology, an in-depth study. In 2007, Wang Shiwen and Guan Minxin research group found a Han Chinese family with a typical maternally inherited characteristics, the family from the hongtong County in Shanxi province. Study finds that the pedigree with matrilineal mitochondrial 4,263 mutation carried by members, 15 people in its 27 matrilineal family members suffering from high blood pressure, matriarchal members of hypertension prevalence as high as 55.6%, is much higher than non-matriarchal members, showing genetic early onset phenomenon. In response, the research group of the United States Cincinnati Children's Hospital and Austria Vienna Medical University collaborative research, found 4,263 mutation of mitochondria, leading to mitochondrial dysfunction, causing blood pressure to rise.researchers point out that, in patients with essential hypertension in China, some 8 million cases of high blood pressure or been part under the influence of variation in mitochondria. The subject study on hypertension early genetic diagnosis and prevention of diseases, in particular targeted target treatment will have a profound impact, and for the study of hereditary hypertension develop a new field.   

Tobacco keep away from women

2009 who report shows global tobacco epidemic second-hand smoke can trigger various diseases at present, the apart from secondhand smoke on female health threats (), increasing tobacco advertisements are targeted links to female, especially young female. According to the World Health Organization (WHO) survey of 151 countries, around 7% female smoking among young people, while the proportion of smoking among male youth is 12%. In some countries, adolescent girls and boys to smoke almost quite.   

Tobacco marketing endangers wo

Advertisement incorrectly female beauty, tobacco use and linked to the empowerment of women and health, and in fact, tobacco addiction is the female into a slave to tobacco, and will break the women's appearance. Using misleading information to lure women, such as "mild" or "low tar". Suck "mild"   cigarettes women than men which was frequently because they incorrectly think "mild" means that   "more security".   

Today's prostate cancer treatm

Beijing Cancer Hospital and the Cancer Institute of Urology Ming Li set out of Beijing, in today's treatment of prostate cancer, hormone therapy remains the most important means of treatment of advanced prostate cancer, intermittent hormone therapy can be used in patients with partial-selective, endocrine therapy combined with radical surgery and radiation therapy is also important means of prostate cancer treatment, especially for high-risk prostate cancer. Radical resection of is the most effective method of treatment limitations of prostate cancer, currently newer technologies including retained the Neurovascular bundle of radical resection of prostate cancer, laparoscopy and the da Vinci robot-assisted laparoscopic radical prostatectomy surgery. In addition, also included in the treatment of prostate cancer radiotherapy, cryotherapy and high intensity focused ultrasound therapy for the treatment of partial methods (Journal of Chinese medicine  2008,88:649).   

Toe induction finger

Harbin Medical University Hospital has recently successfully completed a case (left foot right) jointly with the 2nd toe bone flap transplantation for reconstruction of thumb. Patients are males aged 20, 8 months ago due to accidents, resulting in comminuted fracture of right thumb, hospital for replantation surgery, postoperative necrosis of the thumb. Subsequent patients in Harbin Medical University Hospital, a branch of the external Professor Guan Dehong decisions for its implementation (left foot right) jointly with the 2nd toe bone flap transplantation for reconstruction of thumb. Surgery lasted 12 hours total, doctors root vascular anastomosis of a total of 3, 3, and 1 nerve root tendon. After operation, patients recover and it was good, thumbs blood supply is good. &Nbsp, (Nie Songyi   Li hua   yangfan)    

Tolerance is a big

Remembers more than 10 years I is head of medicine neurosurgery credits in Jiangxi province, society Office delivered some magazines for reading, having a not very familiar with or not catching the Tribune style=color:Blue> Chinese medical Tribune. Indeed, in various sorts of newspapers and the sea, at that time, the Chinese medical Tribune is nothing but a small size newspaper. But I don't know why? When I first with its "intimate", I feel it has a unique charm, deeply attracted me out. Just divided hate late regrets. Thus, in later years, our weekly "dating" again, rain or shine, unshakable. We made known, know to know and as time goes I and become the contribution, though light like water but thick like honey. Through the reading of each issue of the newspaper, although I think the Chinese medical Tribune is a "small", but it is a distinctive, taste and a good level of the medical profession.　　Its outstanding performance in a new, full, live on these three words, in the greatness, so that readers benefit. The so-called "new" is the new topics, new information, some new, attractive eye, often gives rise to a new experience. For example on a number of reports of international conferences, is both timely and focused and concise and clear.　　Lines so people like taste to steaming hot again and again "nutrition meal", learned many new knowledge and new ideas. The so-called "Congress", is on a new basis, branch balance, stay focused and comprehensive overview.　　Some time ago on the Interventional treatment of cardio-cerebral-vascular disease, drug usage, and so on can be objective and fair introduction was split in formulating, reflecting scientific and realistic newspaper. The so-called "live", is reported to have lively and not boring. Key articles have pictures, literary figure and Mau. Rare is the "age", and uninhibited academic festive atmosphere is often full of life, and carry forward.　　"Forum" will be on the. Of course, this newspaper is hardly a great looking, if any, the article is too long, not enough depth .... It also means that a newspaper, and to do best, did go. (Jiangxi   Liu Quan released)